UK markets close in 4 hours 34 minutes

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
32.58+0.16 (+0.49%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,931,613
3,134,328
2,554,609
2,138,587
1,373,105
Cost of revenue
151,214
155,085
146,694
223,218
194,965
Gross profit
2,780,399
2,979,244
2,407,915
1,915,368
1,178,140
Operating expenses
Research development
15,797
17,350
88,130
60,857
7,459
Selling general and administrative
1,695,410
1,806,335
1,456,709
1,199,352
719,208
Total operating expenses
1,546,877
1,750,185
1,655,714
1,338,971
719,273
Operating income or loss
1,233,522
1,229,058
752,200
576,397
458,867
Interest expense
10,760
11,594
14,358
4,329
1,050
Income before tax
908,539
898,195
463,392
254,852
470,315
Income tax expense
88,569
87,950
88,083
41,824
49,653
Income from continuing operations
819,971
810,245
375,309
213,027
420,663
Net income
810,634
800,914
369,840
208,938
418,096
Net income available to common shareholders
810,634
800,914
369,840
208,938
418,096
Basic EPS
3.15
2.48
1.15
0.65
1.30
Diluted EPS
3.15
2.48
1.15
0.65
1.30
Basic average shares
248,612
322,349
322,679
323,357
321,612
Diluted average shares
248,612
322,349
322,679
323,357
321,612